Market closed
Silo Pharma Inc/$SILO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Silo Pharma Inc
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Ticker
$SILO
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
3
ISIN
US82711P2011
Website
Silo Pharma Inc Metrics
BasicAdvanced
$4.8M
-
-$1.13
-
-
Price and volume
Market cap
$4.8M
52-week high
$1.45
52-week low
$0.71
Average daily volume
156K
Financial strength
Current ratio
4.728
Quick ratio
4.599
Interest coverage (TTM)
-931.88%
Management effectiveness
Return on assets (TTM)
-47.90%
Return on equity (TTM)
-99.38%
Valuation
Price to revenue (TTM)
60.62
Price to book
1.2
Price to tangible book (TTM)
1.27
Price to free cash flow (TTM)
-0.943
Growth
Earnings per share change (TTM)
-5.37%
3-year earnings per share growth (CAGR)
-18.99%
Silo Pharma Inc News
AllArticlesVideos
Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
GlobeNewsWire·2 weeks ago
Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug
GlobeNewsWire·2 weeks ago
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Silo Pharma Inc stock?
Silo Pharma Inc (SILO) has a market cap of $4.8M as of May 14, 2025.
What is the P/E ratio for Silo Pharma Inc stock?
The price to earnings (P/E) ratio for Silo Pharma Inc (SILO) stock is 0 as of May 14, 2025.
Does Silo Pharma Inc stock pay dividends?
No, Silo Pharma Inc (SILO) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next Silo Pharma Inc dividend payment date?
Silo Pharma Inc (SILO) stock does not pay dividends to its shareholders.
What is the beta indicator for Silo Pharma Inc?
Silo Pharma Inc (SILO) does not currently have a Beta indicator.